A patient-first, evidence-based guide to reading cardiac strain and whole-body laboratory patterns together.
Heart failure is not simply a "weak heart," and it cannot be confirmed from one blood test. It is a clinical syndrome in which a structural or functional heart problem prevents the circulation from meeting the body's needs without abnormal cardiac pressures. Shortness of breath, swelling, rapid fluid-related weight gain, difficulty lying flat, nighttime breathlessness, fatigue, and reduced exercise capacity may be clues - but lung disease, anemia, kidney disease, thyroid dysfunction, infection, obesity, and deconditioning can produce overlapping symptoms.
Heart failure blood tests help organize that overlap. BNP or NT-proBNP can show that the heart is under increased strain. Kidney, electrolyte, iron, thyroid, glucose, lipid, liver, and urine tests can identify complications, possible contributors, and treatment-safety concerns. Ulta Lab Tests provides direct online access to many of these tests where available, making it easier to establish objective data for a conversation with a qualified healthcare professional.
Medical note: Laboratory testing provides information; it does not replace a medical history, physical examination, electrocardiogram, echocardiogram, imaging, or professional diagnosis. New or worsening heart-failure symptoms require timely clinical evaluation.
Heart failure means the heart cannot fill, pump, or circulate blood efficiently enough for the body's needs without increased pressure inside the heart. The heart has not stopped. The syndrome can result from coronary artery disease, long-standing high blood pressure, valve disease, abnormal rhythms, cardiomyopathy, inflammation, infection, toxins, inherited disease, metabolic disorders, pregnancy-related disease, or other causes.
In June 2026, the American Heart Association, American College of Cardiology, European Society of Cardiology, and World Heart Federation published the Second Universal Definition of Heart Failure. The framework emphasizes earlier identification, a standardized classification of underlying causes, and three clinically actionable ejection-fraction categories: reduced, preserved, and improved. It also recognizes that heart failure can improve, remit, recover, worsen, or progress over time.1,3
Core idea: Ejection fraction is important, but it is only one part of the picture. Symptoms, examination findings, biomarkers, imaging, underlying cause, disease stage, and trajectory all matter.
Laboratory testing answers several different questions at once:
The 2022 AHA/ACC/HFSA heart-failure guideline recommends a broad baseline laboratory evaluation for people diagnosed with heart failure, including a complete blood count, urinalysis, serum electrolytes, blood urea nitrogen, creatinine, glucose, lipid profile, liver tests, iron studies, and thyroid-stimulating hormone. It also recommends BNP or NT-proBNP to support diagnosis or exclusion when a person presents with shortness of breath.2
| Symptom or risk factor | What it may suggest | Laboratory information that may help |
|---|---|---|
| New or progressive shortness of breath; difficulty lying flat; waking breathless | Cardiac congestion, lung disease, anemia, infection, obesity-related limitation, or another cardiopulmonary problem | BNP or NT-proBNP, CBC, CMP, kidney function, and targeted tests based on the clinical evaluation |
| Swollen feet, legs, or abdomen; rapid unexplained weight gain | Fluid retention from heart, kidney, liver, venous, or medication-related causes | BNP or NT-proBNP, creatinine/eGFR, BUN, sodium, albumin, liver markers, urinalysis, and uACR |
| Persistent fatigue, weakness, or reduced exercise capacity | Heart failure, anemia, iron deficiency, thyroid dysfunction, kidney disease, glucose abnormality, or deconditioning | CBC, ferritin/iron/TIBC/TSAT, TSH with Free T4 when indicated, CMP, glucose, and A1C |
| Palpitations or a fast or irregular pulse | Arrhythmia, thyroid excess, electrolyte disturbance, medication effect, or another cardiac condition | TSH, Free T4, electrolytes, and magnesium; an ECG is usually more direct for rhythm assessment |
| High blood pressure, diabetes, obesity, kidney disease, or known coronary disease | Higher risk for developing or worsening heart failure | A1C, glucose, lipid panel, ApoB when appropriate, creatinine/eGFR, and uACR |
| Fever, rash, inflammatory joint symptoms, or muscle weakness with cardiac symptoms | Infection, inflammation, myocarditis, or systemic autoimmune disease | CBC, CRP, ESR, and only symptom-directed antibodies or infectious testing |
Safety note: Call 911 for chest pressure or pain, sudden severe breathlessness, fainting, blue or gray lips, confusion, a weak or markedly irregular pulse, or sudden severe weakness. These findings may signal a heart attack, acute heart failure, pulmonary embolism, or shock. Do not wait for an outpatient laboratory result.7,8
BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) are released in greater amounts when the heart muscle is stretched or working under increased pressure. In a person with symptoms such as breathlessness, swelling, cough, fatigue, or inability to sleep flat, either test can help a clinician decide whether cardiac stress is likely enough to warrant further evaluation.4
BNP and NT-proBNP may also rise with reduced kidney function, older age, atrial fibrillation, valve or heart-muscle disease, pulmonary hypertension, pulmonary embolism, and other serious heart or lung conditions. A high value identifies stress; it does not identify the cause. The result must be integrated with symptoms, blood pressure, kidney function, rhythm, medications, examination findings, ECG, and imaging.
A low natriuretic peptide usually makes heart failure less likely, but obesity can suppress BNP and NT-proBNP concentrations. Some people with heart failure with preserved ejection fraction may also have values below commonly used diagnostic thresholds. Persistent or concerning symptoms can still justify echocardiography or specialist-directed testing.4
They reflect related biology but use different assays, reference information, and clearance pathways. Some medications may also affect them differently. For trend interpretation, it is usually better to follow the same marker through the same laboratory when practical instead of comparing a BNP result directly with a later NT-proBNP value.
No one needs every test below. The appropriate combination depends on symptoms, known diagnoses, medications, previous results, kidney function, and the clinical question.
| Linked test | What it measures and why it matters | General interpretation and limitations |
|---|---|---|
| BNP Test | A cardiac hormone released with myocardial wall stress; helps assess whether heart failure may contribute to compatible symptoms. | Higher values support cardiac stress but are not cause-specific. Lower values may be less reassuring in obesity. Interpret with the assay's range, kidney function, age, rhythm, and imaging. |
| NT-proBNP Test | An inactive peptide fragment released alongside BNP; used for similar diagnostic and prognostic questions. | Higher values can occur with heart failure, kidney dysfunction, atrial fibrillation, age, and other cardiopulmonary disorders. Do not compare its number directly with BNP. |
| CBC with Differential and Platelets | Measures red cells, hemoglobin, white cells, and platelets; looks for anemia, infection clues, and other blood abnormalities that may mimic or worsen symptoms. | Low hemoglobin may contribute to breathlessness or fatigue. Red-cell indices may guide iron, B12, or folate follow-up, but a CBC does not establish the cause of anemia. |
| Comprehensive Metabolic Panel | Combines glucose, kidney markers, electrolytes, liver markers, albumin, and total protein for a broad safety and organ-function baseline. | Patterns may reflect kidney impairment, fluid balance, liver congestion, diabetes risk, nutrition, or medication effects. Hydration, acute illness, and medications can shift several components. |
| Linked test | What it measures and why it matters | General interpretation and limitations |
|---|---|---|
| Creatinine Test, Blood Urea Nitrogen (BUN) Test, eGFR, Sodium Test, Potassium Test, and Carbon Dioxide (Bicarbonate) Test | Usually available within a CMP; helps assess filtration, fluid/electrolyte balance, and medication safety. | Rising creatinine or falling eGFR may reflect chronic kidney disease, acute kidney injury, altered perfusion, medication effects, or volume changes. A single result does not define the cause. |
| Magnesium Test | Measures serum magnesium, an electrolyte relevant to neuromuscular function and cardiac rhythm. | Low magnesium may occur with some diuretics or gastrointestinal losses. Serum magnesium is useful clinically but does not perfectly represent total-body stores. |
| Urine Albumin-to-Creatinine Ratio | Compares urine albumin with urine creatinine to detect albumin leakage and assess kidney and vascular risk. | Persistent elevation may indicate kidney damage and higher cardiovascular risk. Exercise, fever, urinary infection, and other temporary factors can raise it, so confirmation may be needed.6 |
| Urinalysis Complete Test | Checks urine concentration, protein, blood, glucose, cells, and other findings that can provide kidney or urinary context. | Abnormal findings are not specific and often require follow-up. Normal serum sodium does not prove that dietary sodium intake is low. |
| Linked test | What it measures and why it matters | General interpretation and limitations |
|---|---|---|
| Iron, TIBC, and Ferritin Panel | Measures stored iron, circulating iron, binding capacity, and calculated transferrin saturation (TSAT); helps identify reduced iron availability. | The traditional heart-failure iron-deficiency pattern is ferritin below 100 micrograms/L, or ferritin 100-300 micrograms/L with TSAT below 20%. Ferritin can rise with inflammation, so TSAT and the CBC matter.5 |
| Vitamin B12 and Folate Panel Test | Evaluates two nutrients needed for red-cell production; most useful when macrocytosis, dietary risk, malabsorption, or neurologic symptoms are present. | Not a routine heart-failure test for everyone. Borderline results may require clinical correlation or more specific follow-up testing. |
Iron deficiency deserves special attention because it can reduce exercise capacity and quality of life even without anemia. Ferritin should not be interpreted alone: inflammation can elevate ferritin despite limited usable iron. Decisions about oral or intravenous iron depend on the heart-failure phenotype, symptoms, hemoglobin, kidney function, source of iron loss, and clinician assessment. A direct-access result should not prompt self-treatment with iron.
| Linked test | What it measures and why it matters | General interpretation and limitations |
|---|---|---|
| TSH and Free T4 Test | Assesses the pituitary-thyroid feedback pattern. Thyroid excess can increase heart rate and rhythm stress; thyroid deficiency can contribute to fatigue, fluid retention, slower heart rate, and adverse lipid patterns. | TSH is recommended in the baseline heart-failure evaluation. Acute illness, medications, pregnancy, supplements such as biotin, and pituitary disease can complicate interpretation. |
| Hemoglobin A1C Test | Estimates average glucose exposure over roughly two to three months; identifies a major cardiometabolic risk factor. | Anemia, altered red-cell turnover, kidney disease, hemoglobin variants, and recent blood loss or transfusion may affect A1C. Confirm unexpected patterns with a healthcare professional. |
| Lipid Panel and Apolipoprotein B Test | Characterize cholesterol, triglycerides, and atherogenic particle burden; useful for assessing coronary and metabolic drivers of heart-failure risk. | These tests assess risk and contributing disease, not current congestion. Fasting requirements vary by test and clinical question. |
| C-Reactive Protein Test and Sed Rate Test | Nonspecific inflammation markers that may add context when fever, systemic symptoms, infection, or inflammatory disease is suspected. | Not routine screening tests for all heart-failure evaluations. High results do not identify the source; broad autoimmune panels should be symptom-directed. |
For a medically stable person with compatible symptoms, the initial discussion may include one natriuretic peptide (BNP or NT-proBNP), CBC, CMP, creatinine/eGFR, electrolytes, urinalysis, TSH, and iron studies. The exact combination should follow the clinical question; some symptoms require same-day or emergency evaluation rather than self-directed testing.
Free T4, uACR, magnesium, A1C, lipid panel, ApoB, B12/folate, CRP, ESR, or disease-specific tests may be added when the history or initial results support them. Troponin is generally an acute-care cardiac-injury test, not a routine direct-access wellness screen.8
A broader panel can be useful when several systems need evaluation, but more tests are not automatically better. Cardiac confirmation still requires clinical assessment and often an ECG, echocardiogram, chest imaging, and evaluation for coronary artery, valve, rhythm, or heart-muscle disease.
Monitoring may include creatinine/eGFR, potassium, sodium, magnesium, CBC, iron studies, glucose/A1C, liver markers, urine albumin, and sometimes the same natriuretic peptide. The schedule is individualized. The goal is not simply to make BNP "normal"; it is to improve symptoms and function, reduce risk, and maintain kidney and electrolyte safety.
Use the range on your report. Reference intervals and decision thresholds can vary by assay, laboratory, age, sex, and care setting. "Optimal" targets promoted online are not automatically appropriate for heart-failure decisions.
Read connected patterns. A high NT-proBNP with declining eGFR does not have the same meaning as the same NT-proBNP value with stable kidney function. Low hemoglobin plus low ferritin differs from low hemoglobin with normal or elevated ferritin. An abnormal TSH needs thyroid-hormone and clinical context.
Expect biological variation. Hydration, acute illness, medications, fasting, recent exercise, pregnancy, supplements, inflammation, and laboratory methodology can affect results. Biotin can interfere with some thyroid and cardiac assays; disclose all supplements and medications, but do not stop them unless a healthcare professional instructs you to do so.
Normal does not always mean "nothing is wrong." Obesity may lower natriuretic peptides, and some preserved-ejection-fraction cases can have nondiagnostic values. Conversely, an abnormal result does not prove heart failure.
Trend like with like. When practical, compare BNP with prior BNP - or NT-proBNP with prior NT-proBNP - using the same laboratory and similar collection conditions. Interpret the trend alongside weight, swelling, breathing, blood pressure, medications, kidney function, and imaging.
Ulta Lab Tests allows patients to order many laboratory tests directly online where available. Testing is performed through established laboratory networks such as Quest Diagnostics where applicable. Pricing is displayed before ordering, insurance is not required, HSA/FSA payment may be available where accepted, and results are delivered securely online.
Direct access can make it easier to establish a baseline or obtain selected follow-up data, but it does not replace medical evaluation. Use results to support a more informed conversation with a qualified healthcare professional who can integrate the laboratory pattern with symptoms, examination findings, blood pressure, ECG, echocardiography, imaging, medications, and the underlying cause.
Common heart failure blood tests include either BNP or NT-proBNP, a CBC, CMP, creatinine/eGFR, electrolytes, glucose, iron studies, and TSH. A clinician may add A1C, lipids, ApoB, magnesium, Free T4, or other targeted tests. Blood work supports the evaluation, but confirmation often also requires an ECG, echocardiogram, examination, and sometimes chest imaging.
Both come from the same cardiac hormone pathway and rise when the heart is under increased wall stress. However, they are different molecules with different assays, ranges, clearance, and medication effects. Their numbers are not directly interchangeable. If results will be trended, using the same marker and laboratory is generally more informative than switching between BNP and NT-proBNP.
No. A high result can support cardiac strain, but kidney dysfunction, atrial fibrillation, older age, valve disease, pulmonary hypertension, pulmonary embolism, and other disorders can also raise it. A clinician combines the result with symptoms, examination findings, ECG, echocardiography, and other testing to determine whether heart failure is present and what may be causing it.
Yes, although a low result often makes heart failure less likely. Obesity can lower natriuretic peptide concentrations, and some people with preserved-ejection-fraction heart failure may have values below commonly used thresholds. If breathlessness, swelling, difficulty lying flat, or reduced exercise capacity remains concerning, a healthcare professional may still recommend cardiac imaging or specialist evaluation.
The heart and kidneys regulate circulation, fluid, blood pressure, and electrolytes together. Heart failure can reduce kidney perfusion, while kidney disease can promote fluid retention and raise natriuretic peptide values. Creatinine, eGFR, BUN, potassium, sodium, urinalysis, and uACR also help clinicians assess medication safety and identify chronic kidney damage.
Yes. Iron deficiency can reduce muscle energy use and exercise capacity before hemoglobin becomes low. That is why ferritin is interpreted with transferrin saturation and the CBC. In heart-failure care, the traditional pattern is ferritin below 100 micrograms/L, or ferritin 100-300 micrograms/L with TSAT below 20%. Treatment decisions require clinician review.
Too much thyroid hormone can cause a fast heart rate, palpitations, and high-output cardiac stress. Too little can contribute to fatigue, slower heart rate, fluid retention, and abnormal cholesterol. TSH is part of the recommended baseline laboratory evaluation for established heart failure; Free T4 adds context when TSH is abnormal or the clinical picture warrants it.
BNP and NT-proBNP typically do not require fasting. Other tests ordered at the same time may have different instructions; some lipid and iron products request fasting or morning collection. Always review the preparation instructions for the exact Ulta Lab Tests products in your order. Do not stop medications or supplements unless a healthcare professional tells you to.
Ulta Lab Tests offers direct online ordering for many relevant laboratory tests where available. Direct-access results can provide objective information and support a healthcare conversation, but they cannot confirm heart failure or replace urgent evaluation, examination, ECG, echocardiography, or medication management. Severe or sudden symptoms require emergency care rather than waiting for an outpatient result.
There is no single schedule for everyone. Timing depends on the test, symptoms, kidney function, medications, recent dose changes, baseline potassium, iron status, and clinical stability. A healthcare professional may repeat kidney and electrolyte tests sooner after treatment changes and use longer intervals for stable risk markers. BNP or NT-proBNP should be repeated only when it answers a clinical question.
Heart failure blood tests are most useful as a connected pattern. BNP or NT-proBNP addresses cardiac strain; creatinine, eGFR, electrolytes, urinalysis, and uACR add kidney and fluid context; CBC and iron studies identify anemia or iron deficiency; and thyroid, glucose, A1C, lipid, ApoB, and liver markers help reveal contributors and treatment-safety concerns.
Explore heart and cardiovascular tests at Ulta Lab Tests to compare relevant options and preparation requirements. Order only the tests that fit the clinical question, and review results with a qualified healthcare professional. If symptoms are severe, sudden, or worsening, seek urgent medical care rather than relying on routine outpatient testing.
Commercial disclosure: Ulta Lab Tests offers laboratory-testing services and may link to tests or panels discussed on this page. This content is educational and does not provide individual diagnosis or treatment.
Medical and editorial verification current through August 4, 2026.
Common or first-line when clinically appropriate for compatible symptoms.
BNP and NT-proBNP answer related clinical questions, but their numerical results are not directly interchangeable.
Common or first-line testing.
Common baseline and monitoring tests.
Common, targeted, or follow-up testing depending on the blood-count pattern and history.
Risk-based, targeted, or monitoring tests.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
